WEST PALM BEACH, FL, April 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”) announces that it has filed its Annual Report on Form 10-K on April 15, 2025.
WEST PALM BEACH, FLORIDA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (“FOXO” or the “Company”) announces that it has received a letter from NYSE on August 12, 2025 confirming that NYSE ...
Shares of Minneapolis-based biotech startup Foxo Technologies Inc. began trading on the New York Stock Exchange less than a year ago. Now, the company is already in danger of being removed from the ...
MINNEAPOLIS, MN, Dec. 16, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (FOXO) (NYSE American: FOXO) (the “Company” or “FOXO”) announces that recent transactions have led to the Company having ...
WEST PALM BEACH, FLORIDA, June 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) ("FOXO” or the "Company”) today announced that it formed a new, wholly-owned subsidiary ...
WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) ("FOXO” or the "Company”) today announced that its behavioral health subsidiary, Myrtle Recovery ...
MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc.™ (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance ...
FOXO applies epigenetic science and AI to commercialize saliva-based biomarkers that simplify the consumer underwriting journey and enhance the consumer value proposition FOXO plans to launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results